fbpx

Thought Leadership

When it comes to thought leadership and staying informed, we’ve got you covered. See below for recent articles, webinars, and downloadable resources available.

Want updates like these sent directly to your inbox?

Subscribe to our Newsletters

340B Recertification Window Now Open: Reminder for Hospitals

The Health Resources and Services Administration (HRSA) has set the annual recertification window for the 340B Drug Pricing Program for hospitals from August 12, 2024 to September 9, 2024. The […]

Learn More

340B Recertification Reminder for Consolidated Health Centers & FQHC Look-a-Likes

This is your 340B recertification reminder for 2024. The 2024 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, […]

Learn More

Final Hospital 340B Outpatient Prospective Payment System (OPPS) Remedy

On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) released a final rule around the 340B outpatient prospective payment system (OPPS), outlining a plan to correct and […]

Learn More

Proposed 340B Outpatient Prospective Payment System (OPPS) Solution

On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022, including a […]

Learn More

340B Medicare Reimbursement Adjustments

Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 […]

Learn More

340B Hospitals Impacted by Supreme Court Decision

In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should […]

Learn More

340B Hospitals Affected by COVID-19 Update

Great news for 340B Hospitals affected by COVID-19. On March 15, 2022, President Biden signed into law the $1.5 trillion Consolidated Appropriations Acts, 2022. This bill allows Hospitals that have […]

Learn More

On-Demand Webinar: 340B Program Quarterly Update

The 340B Program has seen a lot of changes in 2021. Join Blue & Co.’s Apexus Advanced 340B Experts for a webinar on Thursday, July 15 at 12:00 p.m. In […]

Learn More
340B Program HRSA Response

340B Program HRSA Response to Pharmaceutical Manufacturers

After months of pharmaceutical manufacturers placing restrictions on the 340B Program to both contract pharmacies and covered entities, HRSA sent letters to six pharmaceutical manufacturers stating they violated the 340B […]

Learn More
Future of the 340B Program

On-Demand Webinar: The Future of the 340B Program

Over the past year, there have been many changes within the 340B Program. Join Jason Prokopik from Blue & Co., LLC and Wes Butler from Barnett Benvenuti & Butler on […]

Learn More
Rural Health Clinic Reimbursement Changes

Rural Health Clinic Reimbursement Changes and Opportunities

On December 27, 2020, President Trump signed into law the Consolidated Appropriations Act (CAA), 2021. Included in this bill are comprehensive Rural Health Clinic reimbursement changes and provide possible new opportunities […]

Learn More
Pharmacy Consulting Group

Pharmacy Consulting Group: Expanding Blue’s Services

Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of […]

Learn More
2021 Grantee recertification

2021 Grantee 340B Recertification Reminder: Consolidated Health Centers and FQHC Look-ALikes

The 2021 Grantee 340B Recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung Programs, Urban Indian, and Tribal […]

Learn More
Working on 340B Program Strategy.

Retail Pharmacy Strategy: Is it Time for Your Organization or 340B Program to Consider One?

With current attacks on the 340B Program by some pharmaceutical manufacturers and other challenges affecting patients in need of prescription drugs, is it time for your Hospital or Health Center […]

Learn More
340B 9.4.20 Updates

Additional Challenges Arise for Protecting the 340B Program

340B covered entities have likely felt bombarded during the last few weeks with various letters from manufacturers, word of additional cuts in Medicare part B drug reimbursement for some hospitals, […]

Learn More

Webinars

340B Recertification Window Now Open: Reminder for Hospitals

The Health Resources and Services Administration (HRSA) has set the annual recertification window for the 340B Drug Pricing Program for hospitals from August 12, 2024 to September 9, 2024. The […]

Learn More

340B Recertification Reminder for Consolidated Health Centers & FQHC Look-a-Likes

This is your 340B recertification reminder for 2024. The 2024 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, […]

Learn More

Final Hospital 340B Outpatient Prospective Payment System (OPPS) Remedy

On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) released a final rule around the 340B outpatient prospective payment system (OPPS), outlining a plan to correct and […]

Learn More

Proposed 340B Outpatient Prospective Payment System (OPPS) Solution

On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022, including a […]

Learn More

340B Medicare Reimbursement Adjustments

Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 […]

Learn More

340B Hospitals Impacted by Supreme Court Decision

In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should […]

Learn More